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Abstract
Background: A new era of flu surveillance has already started based on the genetic characterization and
exploration of influenza virus evolution at whole-genome scale. Although this has been prioritized by national and
international health authorities, the demanded technological transition to whole-genome sequencing (WGS)-based
flu surveillance has been particularly delayed by the lack of bioinformatics infrastructures and/or expertise to deal
with primary next-generation sequencing (NGS) data.
Results: We developed and implemented INSaFLU (“INSide the FLU”), which is the first influenza-oriented
bioinformatics free web-based suite that deals with primary NGS data (reads) towards the automatic generation of
the output data that are actually the core first-line “genetic requests” for effective and timely influenza laboratory
surveillance (e.g., type and sub-type, gene and whole-genome consensus sequences, variants’ annotation,
alignments and phylogenetic trees). By handling NGS data collected from any amplicon-based schema, the
implemented pipeline enables any laboratory to perform multi-step software intensive analyses in a user-friendly
manner without previous advanced training in bioinformatics. INSaFLU gives access to user-restricted sample
databases and projects management, being a transparent and flexible tool specifically designed to automatically
update project outputs as more samples are uploaded. Data integration is thus cumulative and scalable, fitting the
need for a continuous epidemiological surveillance during the flu epidemics. Multiple outputs are provided in
nomenclature-stable and standardized formats that can be explored in situ or through multiple compatible
downstream applications for fine-tuned data analysis. This platform additionally flags samples as “putative mixed
infections” if the population admixture enrolls influenza viruses with clearly distinct genetic backgrounds, and
enriches the traditional “consensus-based” influenza genetic characterization with relevant data on influenza sub-
population diversification through a depth analysis of intra-patient minor variants. This dual approach is expected to
strengthen our ability not only to detect the emergence of antigenic and drug resistance variants but also to
decode alternative pathways of influenza evolution and to unveil intricate routes of transmission.
Conclusions: In summary, INSaFLU supplies public health laboratories and influenza researchers with an open “one
size fits all” framework, potentiating the operationalization of a harmonized multi-country WGS-based surveillance
for influenza virus.
INSaFLU can be accessed through https://insaflu.insa.pt.
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Background
Influenza virus represents a major public health concern
worldwide as it causes annual seasonal epidemics and occa-
sional pandemics leading to high morbidity and mortality
in the population [1, 2]. New viral variants emerge con-
stantly due to the never-ending viral genetic and antigenic
modification as a consequence of mutation events such as
the misincorporation of nucleotides during genome replica-
tion or the exchange of genomic segments [3, 4]. The rate
of virus evolution is further shaped by the impact of the
mutations on the viral fitness as well as by host
immunity-related factors or ecological and environmental
mechanisms, which ultimately drive the timing and fre-
quency of the emergence of novel epidemic threats [3]. As
such, an active molecular-based epidemiological surveil-
lance focused on identifying patterns of viral evolution is a
priority in national policies addressing influenza disease
prevention, control, and therapeutic measures [3]. To per-
form the genetic characterization of the virus, public health
laboratories have traditionally relied on the Sanger sequen-
cing of hemagglutinin (HA) gene, which only partially
covers one of the eight negative-sense single-stranded RNA
segments of the virus genome [5]. Moreover, this approach
almost exclusively focuses the consensus sequences repre-
senting the dominant virus lineage within each infected
host at a particular instant, which has limited our know-
ledge on intra-patient virus population diversity and trans-
mission dynamics [3, 6, 7]. Recently, with the increased
availability of next-generation sequencing (NGS) technolo-
gies allowing rapid and affordable whole-genome sequen-
cing (WGS), a new era of flu surveillance has started based
on genetic analysis of influenza virus at whole-genome scale
[8–10]. This transition is expected to reinforce the ability of
public health laboratories to (i) monitor genetic profiles of
circulating influenza viruses or the emergence of pandemic
influenza strains, (ii) detect epitope and antiviral drug re-
sistance mutations, (iii) perform early season risk assess-
ment, (iv) strengthen vaccine effectiveness analysis, and (v)
optimize pre-season vaccine strain selection. In this con-
text, there is a growing suite of influenza-specific web plat-
forms that comprehensibly allow, for instance, the
annotation of phenotype-associated sequence markers,
genotyping or classification of hemagglutinin (HA) clades,
the prediction of novel variant proteins, or even the assess-
ment of temporal and geographical virus spread (e.g., Influ-
enza Research Database/Fludb, Nextflu, EpiFLU/GISAID,
NCBI InfluenzaVirus Resource, OpenFluDB) [11–15]. Des-
pite their undeniable usefulness and relevance to the era of
NGS-based influenza surveillance, those web-based bio-
informatics tools almost exclusively rely on interrogating
user-provided sequence or phylogenetic data (downstream
steps). In fact, little advance has been achieved to provide
public health laboratories with “influenza-specific” bioinfor-
matics tools to deal with primary NGS data (upstream steps),
which has been pointed out as the main obstacle for
the demanded technological transition for flu surveil-
lance [8]. Many laboratories do not have bioinformat-
ics capabilities and/or staff needed to timely analyze
the generated NGS data [8, 16], and, to date, NGS
data has been essentially handled through in-house
command-line-based pipelines or through wide
multi-usage open-source (e.g., Galaxy) or commercial
platforms (e.g., Geneious, CLC Genomics Workbench
from QIAGEN, Bionumerics from Applied Maths or
Ridom SeqSphere+ from Ridom Bioinformatics) [8,
10, 17, 18]. In this context, taking advantage of the
recent availability of several multiplex RT-PCR assays
for whole-genome amplification of influenza virus [8,
19–24], we built a free bioinformatics web-based suite
that deals with primary NGS data (reads) towards the
automatic generation of the key genetic output data
in a reproducible, transparent, and harmonized man-
ner that fits the disease specificities and short-term
goals for (nearly) real-time flu surveillance.
Implementation
Overview
The bioinformatics pipeline developed and implemented
in the INSaFLU web platform currently consists of six
core steps: (1) read quality analysis and improvement,
(2) type and sub-type identification, (3) variant detection
and consensus generation, (4) coverage analysis, (5)
alignment/phylogeny, (6) intra-host minor variant detec-
tion (and uncovering of putative mixed infections)
(Fig. 1). A summary of the INSaFLU current outputs is
presented in Table 1. A link [25] to the latest documen-
tation for each module, including software settings and
current versions, is provided at the website (https://insa-
flu.insa.pt) (the documentation at the time this article
was published can be found in the Additional file 1; not-
able changes in INSaFLU platform will be continuously
reported in the documentation’s “change log” tab).
Read quality analysis and improvement
This module is the first step in almost all WGS bio-
informatics analyses and refers to the quality control
and improvement of the raw sequencing data. INSa-
FLU currently accepts single- and paired-end reads
(fastq.gz format) generated through widely used NGS
technologies, such as Illumina or Ion Torrent. Reads’
quality control in the INSaFLU pipeline is performed
by using FastQC software [26], while quality improve-
ment is achieved through Trimmomatic [27]. This
tool sequentially (i) performs a trimming sliding win-
dow by cutting reads once the average quality within
a base window falls below a threshold of quality
score, (ii) removes very low-quality bases (or N bases)
from both the start and the end of each read if their
Borges et al. Genome Medicine  (2018) 10:46 Page 2 of 13
quality falls below the specified minimum quality re-
quired, (iii) excludes reads that fall below a specified
length, and (iv) standardize the quality scores by con-
verting them to Phred-33 scores. This first module is
automatically run upon reads upload (i.e., no user
intervention is needed) and provides the following
outputs: (i) FastQC graphical reports (“html” format)
of well-established statistics of the reads quality be-
fore and after Trimmomatic analysis and (ii) quality
processed reads (“fastq.gz” format).
Fig. 1 INSaFLU bioinformatics workflow. The diagram (see schematic legend) illustrates all steps of the bioinformatics pipeline developed and
implemented in the INSaFLU web platform, enrolling six core modules: (1) read quality analysis and improvement, (2) type and sub-type
identification, (3) variant detection and consensus generation, (4) coverage analysis, (5) alignment/phylogeny, and (6) intra-host minor variant
detection. Among other features, INSaFLU also determines “putative mixed infections” at two levels: (i) if more than one type, HA or NA subtype
or lineage is detected and/or (ii) if the relative proportion of intra-host SNVs at frequency 1–50% (minor iSNVs) and 50–90% satisfies empirically
derived criteria (specific alerts are also generated for each case). A detailed description of the INSaFLU outputs is presented in Table 1.
Documentation for each module, including software settings and current versions, is provided at the website (https://insaflu.insa.pt)
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Table 1 INSaFLU outputs
Module Output Format(s) Description Tab for visualization/download
Read quality analysis
and improvement
FastQC report
(raw reads)
.html FastQC graphical quality
reports for raw read
files uploaded
Samples/extra info
FastQC report
(quality processed reads)
.html FastQC graphical quality
reports for quality processed reads
Samples/extra info
Quality processed
reads (1P and 2P)
.fastq.gz Uploaded reads after
quality improvement
using Trimmomatic
Samples/extra info
Type and
sub-type
identification
Influenza type and
sub-type/lineage
graphical INSaFLU detects the
influenza A and B types,
as well as all currently
defined influenza A subtypes
(18 hemagglutinin subtypes
and 11 neuraminidase subtypes)
and the two influenza B lineages
(Yamagata and Victoria)
Samples/type and subtype
(output also included
in each project’s
“Sample list” table)
Draft assembly .fasta Draft de novo assembly
used for type and sub-type/lineage
identification. “Influenza-specific”
contigs are assigned both to
the corresponding viral
segments number and to a
related reference influenza
virus (see next output).
Samples/extra info/type
and subtype/lineage identification >
“Draft assembly”
Assignment of viral
segments and references
.tsv Tab-separated file, where
each “influenza-specific”
NODE (or contig) is assigned
both to the corresponding
viral segment number
(“GENE” column) and
to a related reference
influenza virus
(“ACCESSION” column).
Samples/extra info/type
and subtype/lineage identification >
“Seg./Ref. to contigs”
Variant detection
and consensus
generation
Annotated reference file .gbk Uploaded reference
genome (in .fasta)
annotated using Prokka
References/GenBank file
Mapping file .bam/graphical Binary file storing aligned
reads to a reference
sequence (multi-mapping
and unmapped reads
are not included); the
index is also provided
(.bam.bai). “.bam” files
can be explored in situ
using the Integrative
Genomics Viewer (IGV)
Projects/show project
results/show sample detail
results/mapping file by IGV
Annotated variants
(SNPs and indels)
per sample
.tab/.vcf List of annotated
variants assumed in the
consensus sequences
(for each sample)*
Projects/show project
results/show sample detail
results/mapping file by IGV
Annotated variants
(SNPs and indels)
per project
.tsv Compiles all lists of annotated
variants assumed in the
consensus sequences*
Projects/show project
results/project
“name” > variants
Consensus sequences
per sample
(for the pool of loci)
.fasta A version of the reference
sequence with all validated
variants replaced. Note:
sequences are exclusively
generated for locus with
100% of its length covered
by ≥ 10-fold)*
Projects/show project
results/show sample
detail results
Coverage analysis Coverage report
per project
.tsv Compiles the coverage
reports for each sample,
including the following data:
mean depth of coverage per
locus, % of locus size
covered by at least
1-fold and % of locus
size covered by at least 10-fold.
Projects/show project
results/project
“name” > coverage
graphical Projects/show project results
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Table 1 INSaFLU outputs (Continued)
Module Output Format(s) Description Tab for visualization/download
Coverage report
per sample per
locus (interactive
color-coded statistics)
Green: % of locus size
covered by at least
1-fold = 100% and %
of locus size covered
by at least 10-fold = 100%;
Yellow: % of locus size
covered by at least
1-fold = 100% and %
of locus size covered
by at least 10-fold < 100%;
Red: % of locus size
covered by at least
1-fold < 100% and %
of locus size covered
by at least 10-fold < 100%;
Coverage report per
sample per locus (plot)
graphical Plot of the depth of
coverage throughout each locus
Projects/show project results
Alignment/
phylogeny
Consensus nucleotide
alignments per locus
.fasta/.nex/
graphical
Locus-specific consensus
nucleotide alignments.
NOTE1: consensus sequences
are exclusively generated
for locus with 100% of its
length covered by ≥ 10-fold).
Note 2: The “.fasta” files
can be directly uploaded,
together with associated
metadata (“Sample_list.tsv”),
to visualization tools,
such as PHYLOViZ.
Projects/show project
results/nucleotide
alignments by MSAViewer
Consensus nucleotide alignments—whole
genome
.fasta/.nex/
graphical
Consensus nucleotide
alignments of the “whole
genome” sequences
(i.e., upon concatenation
of all individual locus).
Note 1: whole-genome
sequences are exclusively
generated for samples
with all loci with 100%
of its length covered by
≥ 10-fold. NOTE2: The “.fasta”
files can be directly uploaded,
together with associated
metadata (“Sample_list.tsv”),
to visualization tools,
such as PHYLOViZ.
Projects/show project
results/nucleotide
alignments by MSAViewer
Consensus amino
acid alignments
per encoded protein
.fasta/.nex/
graphical
Consensus amino acid
alignments per encoded
protein. Note: sequences
are exclusively generated
for locus with 100%
of its length covered
by ≥ 10-fold)
Projects/show project
results/amino acid
alignments by MSAViewer
Phylogenetic
tree per locus
.nwk/.tree/
graphical
Maximum likelihood
phylogenetic tree for each
locus-specific nucleotide
alignment. NOTE: The “.nwk”
and “.tree” phylogenetic trees
can be directly uploaded,
together with associated
metadata (“Sample_list.csv”),
to visualization tools, such
as Microreact and Phandango,
respectively.
Projects/show project
results/phylogenetic
trees by PhyloCanvas
Phylogenetic
tree—whole
genome
.nwk/.tree/
graphical
Maximum likelihood
phylogenetic tree for the
alignments of the “whole-genome”
sequences (upon concatenation
of all individual locus). Note:
The “.nwk” and “.tree”
phylogenetic trees can be
directly uploaded, together
with associated metadata
Projects/show project
results/phylogenetic
trees by PhyloCanvas
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Type and sub-type identification
In the second step of the pipeline (also automatically
run without user involvement), a draft de novo assembly
is performed over the quality processed reads using
SPAdes [28]. Subsequently, the ABRicate tool [29] is ap-
plied to query the draft assemblies against an in house
database (“influenza_typing”) of a set of type- and
sub-type/lineage-specific gene markers that allows the
discrimination of the influenza A and B types, all cur-
rently defined influenza A subtypes (18 hemagglutinin
subtypes and 11 neuraminidase sub-types) and the two
influenza B lineages (Yamagata and Victoria). Using this
approach, INSaFLU provides the automatic identifica-
tion of the influenza virus type and sub-type/lineage just
after reads upload. Of note, samples are flagged as “puta-
tive mixed infections” if more than one type, HA or NA
subtype or lineage is detected, and specific alerts are also
generated if an incomplete type/subtype is assigned. No
incongruence was observed between the in silico deter-
mined types or HA subtypes and the result obtained by
the traditional “pentaplex” real-time RT-PCR assay ap-
plied for influenza diagnosis, typing and sub-typing [30]
for the tested the tested 192 A(H3N2) (dataset 1) and 78
A(H1N1pdm09) (dataset 2) viruses. Also notable is that
both or either the type and/or sub-type/lineage could be
determined for viruses sequenced with very low cover-
age (mean depth of coverage < 5-fold across the eight
amplicons), launching the perspective that this key typ-
ing data can be even retrieved from clinical samples with
vestigial viruses abundance and/or generating very low
PCR yield. The INSaFLU “influenza_typing” database
(Additional file 2: Table S1.A) includes (i) representative
sequences of the gene encoding the matrix protein (MP
or M1 gene) of influenza A and B viruses (to infer the
influenza type A or B), (ii) representative sequences of
the HA gene of each of the 18 currently defined HA
Table 1 INSaFLU outputs (Continued)
Module Output Format(s) Description Tab for visualization/download
(“Sample_list.csv”), to
visualization tools, such
as Microreact and
Phandango, respectively.
Intra-host minor
variant detection
(and uncovering
of putative
mixed infections)
Annotated minor
intra-host single
nucleotide variants
(iSNVs) per project
.tsv Compiles all lists of detected
and annotated minor
iSNVs (i.e., SNV displaying
intra-sample variation at
frequency between 1
and 50% - minor variants).
Projects/show project
results/intra-host
minor variants annotation
and uncovering of
mixed infections
Plots of the proportion
of iSNVs at frequencies
1–50% (minor iSNVs)
and 50–90%
graphical Plots the proportion of iSNV
at frequency at 1–50%
(minor iSNVs) and at
frequency 50–90%. You
may inspect this plot to
uncover infections with
influenza viruses presenting
clearly distinct genetic
backgrounds (so called “mixed infections”).
INSaFLU flags samples as
“putative mixed infections”
if they fulfill the following
cumulative criteria: the ratio
of the number of iSNVs at frequency
1–50% (minor iSNVs) and 50–90%
falls within the range 0.5–2.0
and the sum of the number
of these two categories of
iSNVs exceeds 20. Alternatively,
to account for mixed infections
involving extremely different
viruses (e.g., A/H3N2 and A/H1N1),
the flag is also displayed when
he sum of the two categories
of iSNVs exceeds 100,
regardless of the first criterion.
Extra List of samples per project .csv/.tsv List of samples per project (compiles
all samples’ metadata and additional
INSaFLU outputs). This file can be
directly uploaded, together with
associated alignment or phylogenetic
data, to visualization tools, such
as PHYLOViZ, Microreact and Phandango.
Projects/show project
results/sample list
*As a conservative approach, consensus sequences are exclusively generated for loci with 100% of its length covered by ≥ 10-fold. Still, validated variants falling
within loci not fully covered with ≥ 10-fold, are still included in these lists (these cases are labeled in the column “VARIANTS in INCOMPLETE LOCUS” as YES), so
that users can still retrieve valuable and reliable data (e.g., specific epitope and antiviral drug resistance mutations) from samples with borderline coverage
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sub-types, (iii) representative sequences of the neur-
aminidase (NA) gene of each of the 11 currently defined
NA sub-types, and (iv) HA representative sequences of
the influenza B lineages Yamagata and Victoria. As a
proof of concept, all MP, M1, HA, and NA sequences
available at Influenza Virus Resource (NCBI) - Influenza
Virus Database [31], a total of 184,067 sequences (data-
base accessed in 23–25.10.2017), were screened using
the INSaFLU “influenza_typing” tool. The percentage of
hits correctly assigned exceeded 99.99% for NA and HA
sub-typing and reached 100% for type determination. Of
note, this assay detected several types/sub-types mis-
labeled in the NCBI database (confirmed by BLAST ana-
lyses), so these specific mis-discrepancies were not
account for specificity estimation purposes. Following
the same methodological rationale as described above,
draft assemblies are additionally queried against another
in house database (“influenza_assign_segments2contigs”)
(Additional file 2: Table S1. B) using ABRIcate, enabling
the automatic assignment of assembled contigs/nodes to
each corresponding viral segment and a closely related
reference influenza virus (output is provided as a “.tsv”
table). This feature reinforces the application of INSa-
FLU to (i) analyze viruses for which a closely related
whole-genome sequence is not available (e.g., avian in-
fluenza) at the INSaFLU or other databases (NICBI,
GISAID, etc.), (ii) disclose mixed infections (e.g., by
inspecting the output to find if two contigs assigned with
same viral segment are flagged with distinct reference
influenza viruses), (ii) investigate reassortments (e.g., by
inspecting the output to find whether different reference
viruses are assigned to different viral segments). Note-
worthy, as the database for segments/reference assign-
ment is not as exhaustive as the common influenza
sequence repositories (e.g., Influenza Research Database/
Fludb, Nextflu, EpiFLU/GISAID), it is prudent that users
query those databases or apply other tools (e.g., BEAST,
Giraf or BLAST) for specific purposes, such as the de-
tection/confirmation of reassortments or assignment of
the closest publicly available sequence of each segment.
Yet, the database includes, for instance, representative
virus of the circulating 3C.2a and 3C.2a1 genetic
sub-groups of seasonal A(H3N2) influenza (as defined
by the HA sequence diversity, following ECDC guide-
lines) as well as representative A(H5N1) viruses from
distinct H5 genetic clades, so this INSaFLU feature can
promote both the rapid traditional HA genetic
sub-group classification and the detection of potential
inter- or intra-subtype reassortments during the
WGS-based influenza surveillance.
Altogether, upon sample data submission, INSaFLU
automatically provides a rapid snapshot of
whole-genome backbone of each virus and robustly de-
tects the influenza virus type and sub-type/lineage,
which guides the subsequent reference-based down-
stream module and constitutes an optimal complement
to the traditional real-time RT-PCR assays, as it discrim-
inates any HA and NA influenza A sub-types and both
influenza B lineages.
Variant detection and consensus generation
This step of the pipeline consists of mapping the quality
processed reads against user-specified reference se-
quences, followed by SNP/indel calling and annotation,
and generation of consensus nucleotide sequences. The
current reference database of INSaFLU includes refer-
ence sequences of (i) post-pandemic (2009) vaccine-like/
reference influenza A(H1N1)pdm2009, A(H3N2) and B
viruses (from both Northern and Southern hemispheres)
and (ii) representative virus of multiple combinations of
HA/NA subtypes (i.e., H1N1, H2N2, H5N1, H7N9, etc.)
(check the latest list at the documentation webpage). All
reference sequences at INSaFLU are publicly available at
NCBI (or made available under permission from the au-
thors). The reference files, both in “.fasta” and “.gbk”
(GenBank) format (annotation performed by using
Prokka) [32], have been prepared to fit amplicon-based
schemas capturing the whole coding sequences (CDS) of
the main eight genes of influenza virus (PB2, PB1, PA,
HA, NP, NA, M, and NS). Nonetheless, INSaFLU is
highly flexible and allows handling NGS data collected
from any amplicon-based schema, provided that users fit
the reference files to their amplicon design (users just
have to generate and upload a multi-fasta file containing
reference sequences of the individual amplicons they use
with the precise size of the target sequence). Uploaded
“.fasta” files are annotated using Prokka upon submis-
sion and automatically become available at the
user-restricted reference database. In this module, INSa-
FLU takes advantage of Snippy [33], which is a high flex-
ible multisoftware tool for rapid read mapping (using
Burrows-Wheeler Aligner—BWA [34]), SNP- and indel
calling (using samtools [35] and freebayes [36]), variant
annotation (using SnpEff [37]), and consensus gener-
ation (using vcftools [38]). We selected the following cri-
teria for reads mapping and validating SNPs /indels to
be annotated, listed and assumed in the consensus se-
quences: (i) a minimum mapping quality of ≥ 20, (ii) a
minimum number of 10 quality processed reads cover-
ing the variant position, and (iii) a minimum proportion
of 51% of quality processed reads at the variant position
differing from the reference. As a conservative approach,
for each virus, consensus sequences are exclusively gen-
erated for loci with 100% of its length covered by ≥
10-fold (see below the “Coverage analysis” module for
more details), thus avoiding the generation of incom-
plete sequences that would shrink the nucleotide region
available for genetic diversity analyses. Nonetheless,
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variants that fulfill the above described criteria, but fall
within loci not fully covered with ≥ 10-fold, are still in-
cluded in the list of all variants per sample/project (a
specific flag is provided for these cases), so that users
can still retrieve valuable and reliable data (e.g., specific
epitope and antiviral drug resistance mutations) from
samples with borderline coverage. Users can explore all
output mapping files (“.bam” format) to view and inspect
all reads and variants using the easy-to-use visualization
tool Integrative Genomics Viewer [39] available at INSa-
FLU. These output files are also used in INSaFLU pipe-
line to more complex downstream analyses (see below
the module “Intra-host minor variant analyses”). For
each run (see INSaFLU usage section), users must
choose the reference sequences (in general, the
vaccine-like reference sequences of the season under
surveillance) and the pool of samples to be compared
(viruses sharing the same type/sub-type as the reference
selected, as inferred in the previous module). The option
to map reads against same type and sub-type reference
sequences of the vaccine reference strains not only po-
tentiates the mapping quality but also has the clear ad-
vantage of providing the user with a list of amino acid
replacements properly coded to be reported for surveil-
lance. In fact, the amino acid substitutions (including
key markers of specific clades/genetic groups) that are
reported by National Reference Laboratories to supra-
national health authorities (e.g., reports to ECDC/WHO
via TESSy) are coded against the sequence profile of
vaccine-like strains. In summary, this INSaFLU module
provides the key data that are actually the core first-line
“genetic requests” for effective and timely monitoring of
influenza virus evolution on behalf of seasonal influenza
laboratory surveillance, i.e., the list of variants (assumed
in consensus sequences) and their effect at protein level
and also consensus sequences. The latter constitutes the
whole basis for the downstream phylogenetic inferences
driving the continuous tracking of influenza temporal/
geographical spread.
Coverage analysis
A key standard parameter to take into account when
performing NGS is the mean depth of coverage, defined
as the mean number of times each base shows up in in-
dividual reads (also known as vertical coverage). When
handling small amplicon-based NGS data for virus vari-
ant detection and consensus generation, it is mandatory
to finely inspect the fluctuation of the depth of coverage
throughout each amplicon region [6]. Such inspection of
the so-called horizontal coverage may not only be highly
informative about sequencing-derived artifacts (the
coverage plot should typically follow an invert U shape
per amplicon) but also provides important clues about
the degree of relatedness between the genetic
background of the “query” virus and the reference se-
quence chose for mapping. For instance, obtaining suffi-
cient mean depth of coverage for a given amplicon for
which its complete length was not covered at 100% may
be indicative of miss-mapping due to a high genetic dis-
tance between the reference sequence for that locus and
the virus under sequencing. These phenomena are typic-
ally expected for cases of antigenic shift (reassortment
between viral segments from different strains) or
intra-segment homologous recombination, or even, for
instance, for cases of “mis-subtyping” or “mis-choice” of
the reference sequences (e.g., erroneous mapping of A/
H1N1pdm09 viruses against a vaccine-like A/H3N2 ref-
erence). In this context, we developed the getCoverage.py
script [40], so that INSaFLU automatically provides the
user with a deep analysis of the coverage. Results are
provided both per sample (graphical outputs) and as
batch per project (“tsv” format), by yielding the following
data: mean depth of coverage per locus, % of locus size
covered by at least 1-fold, and % of locus size covered by
at least 10-fold. The latter statistics was chosen both to
fit the minimum depth of coverage for variant calling
and to guide the consensus generation (as described
above), i.e., the consensus sequences are exclusively pro-
vided for amplicons fulfilling the criteria of having 100%
of their size covered by at least 10-fold. In addition, INSa-
FLU interactively yields intuitive color-coded outputs of
the coverage statistics as well as depth of coverage plots
for each locus per sample, enabling users to fine-tune this
important parameter towards the uncovering of eventual
atypical but highly relevant genetic events, such as reas-
sortment/homologous recombination events.
Alignment/phylogeny
This module generates harmonized sequence and phylo-
genetic data that can be directly applied for fine-tuned
downstream analysis and visualization platforms, thus
promoting the operationalization of a harmonized supra-
national WGS-based surveillance of influenza virus [8,
41]. First, filtered consensus nucleotide sequences are
used as input to progressiveMAUVE [42] and MAFFT
[43] for draft and subsequent refined sequence align-
ment, respectively. INSaFLU provides refined nucleotide
sequence alignments (FASTA and NEXUS formats) both
at locus level, i.e., for each one of amplicon targets
(which are, in general, influenza CDSs), and at “whole--
genome” scale (after concatenation of all amplicon tar-
gets). Amino acid alignments for annotated proteins are
also built using MAFFT [43]. Subsequently, phylogenetic
trees (in standard “.nwk” and “.tree” formats) are in-
ferred for each alignment by maximum likelihood under
the General Time-Reversible (GTR) model (1000 boot-
straps) using double-precision mode of FastTree2 [44].
In order to fulfill the demands of the cumulative data
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acquisition underlying laboratory surveillance through-
out each flu season, for each INSaFLU project, align-
ments and phylogenetic trees are automatically re-build
and updated as more samples are added, making data in-
tegration completely flexible and scalable (see “Usage”
section). Alignments and phylogenetic trees can be ei-
ther downloaded for external exploration or explored in
situ at INSaFLU website using MSAViewer [45] and
PhyloCanvas [46], respectively.
In summary, INSaFLU dynamically builds
ready-to-explore scalable gene- and genome-based align-
ments and phylogenetic trees in standardized nomencla-
tures and formats that are fully compatible with multiple
downstream applications. These include not only other
web-based “surveillance-oriented” platforms for influ-
enza genotyping, phenotypic prediction (e.g., Influenza
Research Database/Fludb and EpiFLU/GISAID), or phy-
logeographical/patient data integration (such as, PHY-
LOViZ, Phandango and Microreact) [47–49], but also
several computationally intensive bioinformatics algo-
rithms commonly applied for fine-tuned research of in-
fluenza evolutionary dynamics, such as inference of
signatures of selection or refined phylogenetics (e.g., the
widely used MEGA, DnaSP, BEAST, and RAxML).
Intra-host minor variant detection (and uncovering of
putative mixed infections)
INSaFLU additionally provides the user the possibility to
get insight on the influenza intra-patient sub-population
dynamics through the scrutiny of minor intra-host single
nucleotide variants (iSNVs), i.e., SNV displaying
intra-sample frequency below 50%. This is achieved by
applying freebayes software [36] over mapping files
(“.bam” format) with the following criteria: (i) excludes
read alignments from analysis if they have a mapping
quality of less than 20, (ii) excludes alleles from iSNV
analysis if their supporting base quality is less than 20,
(iii) requires a minimum of 100-fold depth of coverage
to process a site for iSNV analysis, and (iv) requires at
least 10 reads supporting an alternate allele within a sin-
gle individual to evaluate the iSNV frequency. Once ful-
filling the above previous criteria, no less than 1% of
intra-host frequency of the alternate allele is reported.
As such, in a dynamic manner, distinct minimum iSNV
frequency cut-offs are assumed depending on the depth
of coverage reached at each site, i.e., the identification of
iSNV sites at frequencies of 10, 2, and 1% is only allowed
if the depth of coverage at a particular site exceeds
100-fold, 500-fold, and 1000-fold, respectively. For each
INSaFLU project, results are compiled in a table (“tsv”
format) listing all iSNVs (detected for all project’ sam-
ples) at frequencies between 1 and 50% (reported fre-
quencies refer to the proportion of reads harboring a
nucleotide that is different from the one in the
reference). As above, variant annotation (using SnpEff )
[37] is also provided. Of note, variants at a frequency
above 50%, which correspond to variants included in the
consensus sequences, are filtered out from this table
since they are systematically listed and annotated up-
stream in the pipeline (see module “Variant detection
and consensus generation”). The table can easily be
scrutinized to find sites displaying inter-patient redun-
dancy (i.e., iSNV sites found in more than one individ-
ual). These may for instance constitute the ultimate
genetic clues for disclosing influenza transmission links
[50] or the emergence of antiviral resistance [51, 52].
Similarly to what is outlined in the previous module, this
table is automatically re-build and cumulatively updated
as more samples are added to each INSaFLU project. In
order to additionally enable the detection of infections
with influenza viruses presenting clearly distinct genetic
backgrounds (so called “mixed infections”), INSaFLU
additionally plots the proportion of iSNV at frequency
1–50% (minor iSNVs) and 50–90% detected for each
sample (the positional mapping of iSNVs from these two
categories within each amplicon can also be explored in
the “coverage plots”; see above). A cumulative high pro-
portion of iSNVs at both frequency’ ranges is mostly
likely to represent a mixed infection, in a sense that the
natural intra-patient influenza diversification is expected
to be very low (no more than a few tenths of variants,
most of them at frequency < 10%), within the limit of de-
tection of the currently applied NGS techniques [7, 50,
53]. INSaFLU flags samples as “putative mixed infec-
tions” based on iSNVs if the following cumulative cri-
teria are fulfilled: the ratio of the number of iSNVs at
frequency 1–50% (minor iSNVs) and 50–90% and falls
within the range 0.5–2.0 and the sum of the number of
these two categories of iSNVs exceeds 20. Alternatively,
to account for mixed infections involving extremely dif-
ferent viruses (e.g., A/H3N2 and A/H1N1), the flag is
also displayed when the sum of the two categories of
iSNVs exceeds 100, regardless of the first criterion.
These numerical indicators were empirically inferred
upon multiple testing, including the independent NGS
run of sample replicates constituting “true” mixed infec-
tions (Additional file 3: Figure S1; dataset 1). In order to
further consolidate these criteria, an additional proof of
concept was carried out by running a bona fide dataset
(dataset 3) of artificial mixtures (in triplicate) of
A(H3N2) viruses at various proportions previously gen-
erated by Shepard and colleagues [17]. INSaFLU was
able to detect these same sub-type mixtures at relative
frequency of as far as 99:1, as well as yielded match
“whole-genome” consensus sequences for all mixtures
with the same dominant virus for all triplicates (Add-
itional file 3: Figure S2; dataset 3). Finally, besides this
iSNV-based approach, it is also worth noting that
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samples are also flagged as “putative mixed infections” if
more than one type, HA or NA subtype or lineage is de-
tected (see “Type and subtype identification” module).
In summary, through this module, INSaFLU supplies
public health laboratories and influenza researchers with
relevant data on influenza sub-population diversification
within humans that can be systematically integrated in
parallel with the “classical” data on “consensus-based”
inter-patient virus genetic diversity. Taking into account
the recent findings on this subject [50–55], it is expected
that this dual approach will strengthen not only our abil-
ity to detect the emergence of antigenic and drug resist-
ance variants but also to decode alternative pathways of
influenza evolution and to unveil intricate routes of
transmission.
Pre-NGS design and full pipeline testing
The INSaFLU pipeline has been mainly tested with two
NGS datasets: 192 samples from A(H3N2) viruses (data-
set 1) and 78 samples from A(H1N1) viruses (dataset 2)
(see details below). These were generated in an Illumina
MiSeq apparatus after influenza whole-genome amplifi-
cation with a modified wet-lab protocol based on a pre-
viously reported RT-PCR assay [19–21]. The adapted
pre-NGS protocols, both for influenza A and B viruses,
are provided in the INSaFLU’s documentation and can
be straightforwardly used for the routine generation of
amplicon template for WGS of influenza viruses (irre-
spective of virus sub-type/lineage). Library preparation
was conducted following the Nextera XT DNA Library
Prep Reference Guide and WGS runs (96 samples per
run) were carried out using MiSeq Illumina flow cells to
obtain 2 × 150 paired-end reads (300 cycles). Based on
our experience with the described experimental design,
success (i.e., 100% of the length of the eight influenza
CDS covered by ≥ 10-fold) is largely potentiated if WGS
runs are designed to yield > 150,000 (2 × 75,000) reads
per sample. In fact, above this cut-off, a success of 92%
was achieved when comparing with less than 70% ob-
tained for samples with < 150,000 dedicated reads. As a
prudent approach, users should design NGS runs to go
further this cut-off (e.g., 300,000 reads per sample) in
order to better account for issues arising from both the
PCR (e.g., fluctuations in the percentage of
influenza-specific amplicons across samples and unbal-
anced relative proportions of the in-sample amplicons)
and the NGS run (e.g., low yield and unbalanced demul-
tiplexing of the reads across the samples). INSaFLU
modules (relying on robust and widely used software)
(Fig. 1) were subjected to specific validation tests to
guarantee the generation of accurate outputs, as de-
scribed above. Still, in order to further attest INSaFLU
robustness as a whole, we ran both datasets 1 and 2 with
IRMA (v0.6.1; influenza module; default settings) [17],
which is the CDC command-line bioinformatics solution
for NGS-driven whole-genome assembly and variant de-
tection for RNA viruses, including influenza. Despite
using distinct methodological approaches, both plat-
forms start from raw reads towards the generation of the
main outputs for influenza surveillance. Comparative
analysis of the obtained “whole-genome” consensus se-
quences using INSaFLU versus IRMA demonstrated
similar and robust performance of both pipelines. A
detailed description of this assay is presented in
Additional file 4: Table S2.
Results and discussion
Here, we launch INSaFLU, a freely available platform lo-
cated at the website of the Portuguese National Institute
of Health, Instituto Nacional de Saúde (INSA) Doutor
Ricardo Jorge, Lisbon, Portugal. It can be openly used
upon account creation. This allows data storage/update
in a continuous manner, thus facilitating continuous epi-
demiological surveillance. INSaFLU gives access to pri-
vate sample and reference databases and projects
management. All data is user-restricted, so it will not be
viewable by other users. All that is really needed to use
INSaFLU is a computer with connection to the Internet.
A tutorial providing a complete usage example of data
upload, project launching and management, as well as of
how to visualize/download graphical and sequence/
phylogenetic output data is provided at INSaFLU’s
DOCUMENTATION [25] and through a detailed video
tutorial available at the INSaFLU homepage. Users can
also walkthrough INSaFLU by logging into a “demo” ac-
count [56].
Usage
The web platform architecture is quite intuitive and enrolls
the following main tabs: samples, references, and projects.
Samples
This menu displays all information for all samples
loaded by the user. Required sample-associated data to
be uploaded at INSaFLU include the following:
 NGS data: single- or paired-end reads (fastq.gz for-
mat) obtained through NGS technologies, such as
Illumina or Ion Torrent (reads can be submitted in-
dividually or as a batch);
 Sample metadata: a table file can be uploaded for a
batch of samples (preferable option) or the sample’s
information can be inserted individually at the
INSaFLU platform. In order to link the sample data
to the uploaded read files, the table file [in comma-
separated value (csv) or tab-separated value (tsv)]
should contain the columns “sample name”, “fastq1”,
“fastq2” (mandatory columns to fulfill; “fastq2” is
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exceptionally not fulfilled for single-end data) as well
these additional variables (that may not be fulfilled),
which commonly constitute the typical metadata col-
lected during seasonal influenza surveillance: “data set”,
“vaccine status”, “week”, “onset date”, “collection date”,
“lab reception date”, “latitude”, “longitude”. However,
users may include any other columns with metadata
variables to be associated with samples. An example
table file is provided at the website. The option to up-
load tables enriched with multiple metadata variables
has the clear advantage of allowing their subsequent
direct upload (along to the standardized and multi-
format outputs of INSaFLU: alignments/trees) to
downstream platforms for phylogenetic data
visualization and/or phylogeographical analysis, such as
PHYLOViZ [45], which accepts sample metadata (tab-
separated format) plus alignments (FASTA format),
Phandango [46], which runs sample metadata (csv-sep-
arated format) and a phylogenetic tree (“.tree” format)
or Microreact [47], which takes sample metadata (in
csv-separated format) plus a phylogenetic tree (“.nwk”
format).
Upon submission, INSaFLU automatically updates
samples’ information with read’s quality and typing data,
as well as provides a rapid snapshot of whole-genome
backbone of each virus by assigning influenza segments
and references to a draft assembly.
References
This menu displays all information for all reference se-
quences available at user’s confidential account. INSa-
FLU provides a default reference database including
publicly (NCBI) available (or made available under per-
mission from the authors) sequences from several
post-pandemic (2009) vaccine-like/reference virus and
representative virus of multiple combinations of HA/NA
subtypes. The database includes whole-genome se-
quences (FASTA and GenBank formats) that are ready
to be used for reference-based mapping (see next sec-
tion). Nonetheless, users are allowed to upload add-
itional reference files to a user-restricted reference
database (uploaded “.fasta” files are automatically anno-
tated upon submission).
Projects
This menu allows the creation of scalable projects rely-
ing on the selection of (i) a reference file from the refer-
ence database that fit their amplicon design (i.e., a
multi-fasta file containing reference sequences of the in-
dividual amplicons they use with the precise size of the
target sequence) and (ii) the batch of samples to be in-
cluded in the project. Since the projects are scalable,
users are encouraged to create “umbrella” projects, such
as projects enrolling the mapping of all same sub-type
virus against the vaccine-like reference virus for a given
flu season. Outputs of the project are organized by dy-
namic “expand-and-collapse” panels that allow a
user-friendly visualization/download of all graphical and
sequence output data.
Benefits
INSaFLU is, to the best of our knowledge, the first
influenza-oriented bioinformatics open web-based suite
that deals with primary NGS data (reads) towards the
automatic generation of the output data that are actually
needed for the first-line influenza surveillance (type and
sub-type, gene and whole-genome sequences, alignments
and phylogenetic trees). The main advantages offered by
INSaFLU are the following:
(i) It allows handling NGS data collected from any
amplicon-based schema;
(ii) It enables laboratories to perform advanced, multi-
step software intensive analyses in a user-friendly
manner without previous advanced training in
bioinformatics;
(iii) It is freely available tool that and can be used upon
account creation giving access to user-restricted
sample and reference databases and projects
management;
(iv) It is located at the website of a National Institute of
Health, which ensures confidentiality and ethics;
(v) It is a flexible tool specifically designed to integrate
output data in a cumulative manner, thus fitting the
analytical dynamics underlying a continuous
epidemiological surveillance during the flu epidemics;
(vi)Outputs are provided in nomenclature-stable and
standardized format and can be explored in situ or
through multiple compatible downstream applica-
tions for fine-tuned data analysis.
Future directions
INSaFLU was designed to overcome a major caveat in
field which is the lack of tools for automate manipulation
of raw NGS data for flu whole-genome-based surveillance.
Still, this platform is under active development in order to
have additional features, such as modules to automatically
detect virus reassortment, and perform temporal and geo-
graphical data integration and visualization.
Conclusions
INSaFLU provides an open “one size fits all” framework
that guarantees that the application of WGS-based bio-
informatics for flu surveillance can be easily accessed by
any laboratory around the world with a common com-
puter with access to Internet. It will certainly strengthen
the detection of genetic changes in circulating influenza
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viruses, the detection of potential pandemic influenza
strains, the early season risk assessment and vaccine ef-
fectiveness analysis, the detection of genetic markers asso-
ciated with antiviral resistance, and pre-season vaccine
strain selection. Ultimately, INSaFLU has the potential to
facilitate collaborative initiatives among cross-sectorial
stake-holders enrolled in the flu surveillance, with benefits
for public health.
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